Highlights
- •Few data are available on the use of opioids in the inpatient pediatric setting.
- •These data are important to improve clinical trial methodology for studying opioids in children.
- •Insights may be gleaned regarding potential sources of opioid misuse and abuse.
- •Most of the time opioids are prescribed for short-term acute pain problems.
- •Long-term use is rare, mostly seen in oncology and critical care settings.
Abstract
Perspective
Key words
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of PainReferences
- Age-dependent development of chronic neuropathic pain, allodynia and sensory recovery after upper limb nerve injury in children.J Hand Surg Eur. 2008; 33: 186-191
- A proactive response to prescription opioid abuse.N Engl J Med. 2016; 374: 1480-1485
CDC. Centers for Disease Control and Prevention. National Center for Health Statistics: Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011. Data from the National Vital Statistics System Mortality File. Available at: http://www.cdc.gov/nchs/data/databriefs/db166.htm Accessed January 27, 2017
- Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.J Pain. 2009; 10: 113-130
- CDC guideline for prescribing opioids for chronic pain — United States, 2016 [erratum in 65:295, 2016].MMWR Recomm Rep. 2016; 65: 1-49
- Hospital Inpatient Statistics, 1996. Healthcare Cost and Utilization Project (HCUP) Research Note. AHCPR Pub. No. 99-0034.Agency for Health Care Policy and Research, Rockville, MD1999
- Prescribing of controlled medications to adolescents and young adults in the United States.Pediatrics. 2010; 26: 1108-1116
- Trends in opioid prescriptions among children and adolescents in the United States: A nationally representative study for 1996 to 2012.Pain. 2016; 157: 1021-1027
Joe Manchin: Manchin Condemns Outrageous FDA Decision to Approve OxyContin for 11 Year Olds. Available at: http://www.manchin.senate.gov/public/index.cfm/2015/8/manchin-condemns-outrageous-fda-decision-to-approve-oxycontin-for-11-year-olds Accessed January 27, 2017
- Sources of prescription opioid pain relievers by frequency of past-year nonmedical use: United States, 2008-2011.JAMA Intern Med. 2014; 174: 802-803
- Controlled substance prescribing patterns–Prescription Behavior Surveillance System, eight states, 2013.MMWR Surveill Summ. 2015; 64: 1-14
Physician-Patient Alliance for Health & Safety: The Epidemic of Opioid Overprescribing Suggests the Need for Caution and Careful Monitoring. Available at: http://www.ppahs.org/2016/03/epidemic-of-opioid-overprescribing-suggests-the-need-for-caution-and-careful-monitoring Accessed December 5, 2016
- Trends in the prescription of opioids for adolescents with non-cancer pain.Gen Hosp Psychiatry. 2011; 33: 423-428
- The potential impact on children of the CDC Guideline for Prescribing Opioids for Chronic Pain: Above all, do no harm.JAMA Pediatr. 2016; 170: 425-426
United States Food and Drug Administration: Drug Research and Children. Available at: https://www.fda.gov/drugs/resourcesforyou/consumers/ucm143565.htm Accessed April 17, 2017
United States Food and Drug Administration: Pediatric Regulations. Available at: https://www.accessdata.fda.gov/scripts/cderworld/index.cfm?action=newdrugs:main&unit=4&lesson=1&topic=1 Accessed January 27, 2017
United States Food and Drug Administration, Center for Drug Evaluation and Research: Summary Minutes of the Anesthetic and Analgesic Drug Products Advisory Committee, the Drug Safety and Risk Management Advisory Committee, and the Pediatric Advisory Committee Joint Meeting, September 15-16, 2016. Available at: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM524875.pdf Accessed January 27, 2017
- Characteristics of opioid prescriptions in 2009.JAMA. 2011; 305: 1299-1301
- Neuropathic pain in children: Special considerations.Mayo Clin Proc. 2010; 85: S33-S41
- Variation of opioid use in pediatric inpatients across hospitals in the U.S.J Pain Symptom Manage. 2014; 48: 903-914
Article info
Publication history
Footnotes
Funding for this study was through a philanthropic grant from the Bungie Foundation, Bellevue, Washington.
Gary A. Walco has provided consultation to Pfizer, Inspirion, Purdue, Janssen, and Endo Pharmaceuticals. Steven J. Weisman has provided consultation to Purdue, Pfizer, Janssen, and Gruenenthal, and served as an investigator for studies conducted by Purdue Pharma, Gruenenthal, the Medicine Company, Depomed, Cadence, and Mallinkrodt. None of these relationships are deemed relevant to this study or the contents of the report. Nancy Gove and Jennifer Phillips have no conflicts of interest to declare.
